Effects of etanercept in patients with the metabolic syndrome (II).

Trial Profile

Effects of etanercept in patients with the metabolic syndrome (II).

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2010

At a glance

  • Drugs Etanercept (Primary)
  • Indications Glucose intolerance; Metabolic syndrome; Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Apr 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 29 Sep 2009 Planned end date changed from 1 Sep 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top